1-13 of 13
thrombocytopenia due to immune destruction
Close
Sort by
Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Clinical Trials & Observations
Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2794–2798.
https://doi.org/10.1182/bloodadvances.2021004957
Published: 2021
Journal Articles

Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia

Sabrina Shrestha, Ishac Nazy, James W. Smith, John G. Kelton, Donald M. Arnold
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2962–2966.
https://doi.org/10.1182/bloodadvances.2020001846
Published: 2020
Includes: Supplemental data
Journal Articles

Positivity rate of systematic bone marrow smear in patients over 60 years old with newly diagnosed immune thrombocytopenia

Clinical Trials & Observations
Thibault Comont, Johanne Germain, Odile Beyne-Rauzy, Daniel Adoue, Guillaume Moulis, and the CARMEN investigators group
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2136–2138.
https://doi.org/10.1182/bloodadvances.2020001654
Published: 2020
Journal Articles

Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.

Journal: Blood Advances
Blood Adv (2020) 4 (2): 252.
https://doi.org/10.1182/bloodadvances.2019001380
Published: 2020
Journal Articles

A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia

Hanny Al-Samkari, Rachel P. Rosovsky, Rebecca S. Karp Leaf, David B. Smith, Katayoon Goodarzi, Annemarie E. Fogerty, David B. Sykes, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 4 (1): 9–18.
https://doi.org/10.1182/bloodadvances.2019000868
Published: 2019
Includes: Supplemental data
Journal Articles

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

Marie A. Hollenhorst, Hanny Al-Samkari, David J. Kuter
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3515–3521.
https://doi.org/10.1182/bloodadvances.2019000400
Published: 2019
Includes: Supplemental data
Journal Articles

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms

Clinical Trials & Observations
David E. Schmidt, Katja M. J. Heitink-Pollé, Annemieke G. Laarhoven, Marrie C. A. Bruin, Barbera Veldhuisen, Sietse Q. Nagelkerke, Taco W. Kuijpers, Leendert Porcelijn, C. Ellen van der Schoot, Gestur Vidarsson, Masja de Haas
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2003–2012.
https://doi.org/10.1182/bloodadvances.2019000068
Published: 2019
Includes: Supplemental data
Journal Articles

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Clinical Trials & Observations
Cindy E. Neunert, Melissa J. Rose
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1907–1915.
https://doi.org/10.1182/bloodadvances.2019000279
Published: 2019
Journal Articles

Dysregulated megakaryocyte distribution associated with nestin + mesenchymal stem cells in immune thrombocytopenia

Min Wang, Ru Feng, Jia-min Zhang, Lin-lin Xu, Fei-er Feng, Chen-cong Wang, Qian-ming Wang, Xiao-lu Zhu, Yun He, Jing Xue, Hai-xia Fu, Meng Lv, Yuan Kong, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu, Xiao-jun Huang, Xiao-hui Zhang
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1416–1428.
https://doi.org/10.1182/bloodadvances.2018026690
Published: 2019
Includes: Supplemental data
Journal Articles

Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1(24):2295-2301.

Journal: Blood Advances
Blood Adv (2018) 2 (15): 1817.
https://doi.org/10.1182/bloodadvances.2018023309
Published: 2018
Journal Articles

Eltrombopag for use in children with immune thrombocytopenia

Clinical Trials & Observations
Taylor Olmsted Kim, Jenny Despotovic, Michele P. Lambert
Journal: Blood Advances
Blood Adv (2018) 2 (4): 454–461.
https://doi.org/10.1182/bloodadvances.2017010660
Published: 2018
Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2295–2301.
https://doi.org/10.1182/bloodadvances.2017009860
Published: 2017
Journal Articles

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

Clinical Trials & Observations
Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S. Kaplan, James D. McFadyen, Huyen Tran, Tse-Chieh Teh, Shaun Fleming, John V. Catalano, Sanjeev D. Chunilal, Anna Johnston, Stephen S. Opat, Jake Shortt
Journal: Blood Advances
Blood Adv (2016) 1 (1): 31–35.
https://doi.org/10.1182/bloodadvances.2016001412
Published: 2016